Summary
Achelios Therapeutics, Inc.
Description
Achelios Therapeutics primary focus is the development of New Therapeutic Entities (NTE) for the treatment of pain and inflammation by topically delivered medications.
Strengths
- Achelios Therapeutics, Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Achelios Therapeutics, Inc. was founded, the company has grown faster than the industry average
Annual Revenue
Achelios Therapeutics, Inc.'s annual revenue
$953000
Based on Kona Equity data
-
Revenue per employee
$158833
-
Variance of revenue growth
0.51
-
Annual revenue growth since founding
$79416
-
Revenue growth rate from first known quarter to current
-77.9%
Employee Count
6 employees
-
Employee growth rate from first known quarter to current
-76.9%
Executives
Crist Frangakis
President/Ceo
c**@achelios.comMichael Fox
Business Chief & Commercial Officer
m**@achelios.comJohn Fort
Chief Medical Officer
j**@achelios.comPhone Therapeutics
President & Chief Executive Officer
p**@achelios.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Achelios Therapeutics, Inc.
- Category: Biotechnology
- Industry: Pharmaceutical Company
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Durham Small Pharmaceutical Company in Durham Mid-size Pharmaceutical Company in Durham Biotechnology in Durham Small Biotechnology in Durham Mid-size Biotechnology in Durham
-
By State NC Small companies in NC Biotechnology in NC Small Biotechnology in NC Mid-size Biotechnology in NC Small Pharmaceutical Company in NC Mid-size Pharmaceutical Company in NC
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Biotechnology and Pharmaceutical Company
-
Firmographic data G Score of 6 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Achelios Therapeutics, Inc.'s headquarters are located at 4364 S. Alston Ave., Ste. 300 Durham, NC 27713.
Achelios Therapeutics, Inc.'s official website is achelios.com
Achelios Therapeutics, Inc.'s annual revenue is $953.0 K.
Achelios Therapeutics, Inc.'s SIC: 2834; 283
Achelios Therapeutics, Inc.'s NAICS: 32541; 3254.
Achelios Therapeutics, Inc. has 6 employees
Achelios Therapeutics, Inc. is in the industry of Biotechnology.